Screener
Iovance Biotherapeutics, Inc. IOVA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$47.32M+57.6% | -$79.05M+32.0% | -$71.9M+8.5% | -$91.25M-9.2% | -$111.66M-15.0% | ||
| $3.78M+11.3% | $2.82M+9.8% | $3.72M+13.7% | $3.19M+6.3% | $3.4M+13.3% | ||
| $11.73M-21.5% | $11.27M-50.8% | $11.82M-61.9% | $11.9M-61.6% | $14.94M-51.0% | ||
| -$60.84M+9.8% | -$72.07M+30.5% | -$52.57M+28.3% | -$78.7M-33.5% | -$67.45M+31.5% | ||
| $5.44M-27.1% | $6.61M+6.4% | $9.32M+124% | $10.84M+374% | $7.46M+1,588% | ||
| -$74.05M-635% | $11.39M-28.2% | $775K— | $17.01M+135% | $13.84M— | ||
| $49.29M+273% | $94.34M-34.2% | $56.17M+2,333% | $88.06M+110% | $13.23M-91.3% | ||
| -$85.73M— | $33.44M-40.3% | $4.96M+110% | $25.69M+140% | —— | ||
| -$66.28M+11.5% | -$78.68M+28.4% | -$61.89M+20.1% | -$89.55M-46.2% | -$74.91M+24.2% |
FAQ
- How much cash does Iovance Biotherapeutics, Inc. generate?
- Iovance Biotherapeutics, Inc. (IOVA) generated -$264.2M in operating cash flow over the trailing twelve months.
- What is Iovance Biotherapeutics, Inc.'s free cash flow?
- After $32.2M of capital expenditures, Iovance Biotherapeutics, Inc.'s free cash flow was -$296.4M over the trailing twelve months, up 8.4% year over year.
- Where does Iovance Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Iovance Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
